Stants Kristen
Chief People Officer at DNTH
- Sold, on record
- $39k
- Dollars the filings state
- Form 4 sales
- 1
- Latest Sep 16, 2021
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- DNTHDianthus Therapeutics, Inc. /DE/Chief People Officer
Sales by reason
0
Routine
0
Plan not stated
0
No plan
1
Unusual
Form 4 sales per year, every sale on record.
Timeline
- Sep 16, 2021Unusual
Sold 28.7% of their holdings
$39k5,736 shares at $6.73
1 of 1
Every transaction
| Traded | Filed | Stock | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|
| Nov 30, 2022 | Dec 2, 2022 | DNTH | Chief People Officer | Awarded | 3,000 | $0.94 | $3k | 20,264 | SEC |
| Aug 1, 2022 | Aug 1, 2022 | DNTH | Chief People Officer | AwardedStock Option (Right to Buy) | 85,000 | 85,000 | SEC | ||
| May 31, 2022 | Jun 6, 2022 | DNTH | Chief People Officer | Awarded | 3,000 | $0.99 | $3k | 17,264 | SEC |
| May 17, 2022 | May 19, 2022 | DNTH | Chief People Officer | AwardedStock Option (Right to Buy) | 50,000 | 50,000 | SEC | ||
| Feb 15, 2022 | Feb 17, 2022 | DNTH | Chief People Officer | AwardedStock Option (Right to Buy) | 85,000 | 85,000 | SEC | ||
| Sep 16, 2021 | Sep 20, 2021 | DNTH | Chief People Officer | Sold | 5,736 | $6.73 | $39k | 14,264 | SEC |
| Sep 14, 2021 | Sep 16, 2021 | DNTH | Chief People Officer | Awarded | 20,000 | 20,000 | SEC | ||
| Aug 2, 2021 | Aug 3, 2021 | DNTH | Chief People Officer | AwardedStock Option (Right to Buy) | 67,500 | 67,500 | SEC | ||
| Feb 11, 2021 | Feb 16, 2021 | DNTH | Chief People Officer | AwardedStock Option (Right to Buy) | 67,500 | 67,500 | SEC |